GeneCare Research Institute Co.,Ltd.
Home
Profile
Corporate Information
Corporate History
Message from the President
Business Overview
Research & Development
News
News & Release
Topics
Recruiting Information
Contacts
Topics
August 15, 2007

It sends to BioJapan2007 for display (9 / 19-21 Pacifico Yokohama).

 
March 16, 2007 Information of research and development division relocation  
October 13, 2006 A Japanese clinical inspection automatic chemistry meeting original-SNP-analysis-diagnostic-technology-anno  
March 3, 2006 Adoption to the commission development enterprise of a technology promotion mechanism  
November 9, 2005 RNAi applied technology front line seminar (Tokyo Komaba)  
     
- Related articles    
May 21, 2007 It is non-listed biotechnology venture medical research and development, and is presence (Nikkei Industrial  
May 10, 2007 Venture president tip medical treatment is challenged (Nihon Keizai Shimbun).  
October 13, 2006 It is "RNA interference" antineoplastic drug development of the Nobel Prize technology, and is a result (Nihon Keizai Shimbun).  
August, 2005 "Breakthrough power of RNAi" (the Nikkei biotechnology business)  
March, 2005 It is "the new antineoplastic drug which aims at helicase by Achilles tendon RNAi of cancer" (the Nikkei biotechnology business).  
January 17, 2005 "The male of RNAi drug design, U.S. Alnylam, a tie-up" (Nikkei Biotec)  
January 12, 2005

"A new anti-cancer medicine development U.S. company and a patent contract" (Nihon Keizai Shimbun)

 
Download Adobe Reader
Get Adobe Reader Click here to go to the Adobe Reader download site.
Copyright GeneCare Research Institute Co.,Ltd. All rights reserved. top